A First-in-Human Phase 1 Safety and Biodistribution of [177Lu]Lu-ABY-271 in Subjects With HER2-positive Metastatic Breast Cancer
Clinical trial NCT07081555 · RECRUITING
Trial details
- NCT number
- NCT07081555
- Sponsor
- Affibody
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-06
- Primary completion
- 2027-01-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.